Participants
Deal Summary
ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, announced a $13 million seed financing round on May 7, 2026. The funding will support the development of its mRNA therapeutics platform.
Comments
Want to join the conversation?
Loading comments...